Preclinical Safety Assessment of a Polyherbal Formulation: Acute, Subchronic, and Mutagenic Evaluation

Enkhmaa Gonchig 1 , Chimgee Tserendash 1 , Maral-Erdene Gerelt-Od 1 , Batdavaa Batbayar 1 , Mend-Amar Batbaatar 1 , Perleidulam Bunddulam 2 , Enerel Yeruult 2 , Narankhajid Myadagsuren 3 , Otgonbat Altangerel 4 *, Yeruult Chultemsuren 1 * Mongolia's rich biodiversity and long-standing tradition of herbal medicine use offer a strong foundation for developing plant-based therapeutics.Plants containing bioactive compounds, such as flavonoids, cynarin, alkaloids, glycosides, quercetin, rutin, luteolin, and vitamin C, are typically employed for their well-documented anti-inflammatory, antioxidant, and antibacterial properties [12][13][14] .These